Combining HPV and MIB-1 tests reduces the number of colposcopies in women with equivocal cytology

Acta Obstetricia et Gynecologica Scandinavica

Volumn 85, Issue 12, 2006, Pages 1491-1495

  Wensveen, C W M ^a,b   Kagie, M J ^c   Veldhuizen, R W ^c   Trimbos, J B M Z ^b   Boon, M E ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d LEIDEN CYTOLOGY AND PATHOLOGY LABORATORY   (Netherlands)

Author keywords

Borderline dyskoryosis; Colposcopy; Human papillomavirus; MIB 1 test; Pap smear

Indexed keywords

KI 67 ANTIGEN;

ARTICLE; CELL PROLIFERATION; COLPOSCOPY; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DYSKARYOSIS; EVALUATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PATIENT REFERRAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; CELL DIVISION; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; COLPOSCOPY; DNA, VIRAL; FEMALE; HUMANS; KI-67 ANTIGEN; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33845265060     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340600936001     Document Type: Article

References (21)

1. Cox JT. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus. Baillieres Clin Obstet Gynaecol. 1995;9(1):1-37.
2. Guido R. Guidelines for screening and treatment of cervical disease in the adolescent. J Pediatr Adolesc Gynecol. 2004;17(5):303-11.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-9.
4. Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol. 2002;3(1):11-6.
5. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338(7):423-8.
6. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995;87(18):1365-71.
7. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998;132(2):277-84.
8. Remmink AJ, Walboomers JM, Helmerhorst TJ, Voorhorst FJ, Rozendaal L, Risse EK, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer. 1995;61(3):306-11.
9. Kenemans P. HPV genotype as a prognostic factor for progression to cervical carcinoma in young women. Eur J Obstet Gynecol Reprod Biol. 1994;55(1):24-5.
10. Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol. 2005;99(3 Suppl 1):S7-11.
11. Key G, Becker MH, Baron B, Duchrow M, Schluter C, Flad HD, et al. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest. 1993;68(6):629-36.
12. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA. 1999;281(17):1605-10.
13. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93(4):293-9.
14. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 1995;172(3):946-54.
15. Hanselaar AG. Criteria for organized cervical screening programs. Special emphasis on The Netherlands program. Acta Cytol. 2002;46(4):619-29.
16. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA. 2000;283(1):87-93.
17. Kok LP, Boon ME. Microwave Cookbook for Microscopists: Art and Science of Visualization, third revised edition. Leiden: Coulomb Press; 1992. p. 266.
18. Boon ME, Vinkestein A, van Binsbergen-Ingelse A, van Haaften C. Significance of MiB-1 staining in smears with atypical glandular cells. Diagn Cytopathol. 2004;31(2):77-82.
19. Boon ME, Kleinschmidt-Guy ED, Wijsman-Grootendorst A, Hoogeveen MM. Upgrading unsatisfactory cervical smears with the MiB-1 method. Diagn Cytopathol. 1996;15(4):270-6.
20. Dunton CJ, van Hoeven KH, Kovatich AJ, Oliver RE, Scacheri RQ, Cater JR, et al. Ki-67 antigen staining as an adjunct to identifying cervical intraepithelial neoplasia. Gynecol Oncol. 1997;64(3):451-5.
21. Bekkers RLM. MIB1 and High-Risk HPV Detection as Markers for CIN3 in Cervical Scrapes. Clinical Value of High-Risk HPV Detection in the Management of Cervical Intraepithelial Neoplasia. Nijmegen: Ponsen & Looyen bv, 2003: 99-114.